Ji Vl ek (Absent Minded) Prof. of Clinical pharmacy and - - PowerPoint PPT Presentation

Jiří Vlček

(Absent Minded) Prof. of Clinical pharmacy and Pharmaceutical care Charles University in Prague Clinical pharmacist in University hospital Hradec Králové Czech Republic Chairman of LOC 15th ISoP Meeting vlcek@faf.cuni.cz

¡

§ Population risk Signal of risk no….stop/yesê it is a lot of work to organize a meeting, inter-professional factor § Individual risk Analysis of risk no…..stop/yesê lack of PhD programs in the PV field, we don´t know majority of people from ISoP § Judgement of individual risk Founding of ways of risk measurement no…stop/yesê BENEFIT: Delegates experienced in the PV field coming to Prague, bringing profit to students § How to manage risk Elimination of risk § Strong LOC, support from the University, regulator and industry partners. Hervé´s visit in January 2014 in Prague, proactive PCO: C-IN

Spring 2013: To invite or not to invite ISoP to the Czech Republic? Algorithm SAFE – complete risk minimization activity

Risk signal individual founding elimination rate § Physician ++ ++++ ++++ +++ 13 § Clinical pharmacist ++++ +++ +++ ++++ 14 § Nurse ++ ++ + ++ 7 § Community pharmacist ++ ++ + ++ 7 § Patient + + + + 4

Roles of different professions participating in risk management in algorithm SAFE

§ Patient safety § Scientific method in Pharmacovigilance - PhD projects § Risk management on individual and population level § Individual alert making harm and how they are recognized § Future in PV § Education in PV

The original idea…

1/ Risk management 2/ Herbal safety 3/ PRAC in Prague 4/ Big data 5/ Patient perspective of drug safety 6/ Medication errors 7/ Role of communication in patient safety 8/ Women health

In order to live up to expectations of the “Cubism in pharmacovigilance“ topic of our Meeting, we tried to cover the following fields…

Both cubism in early 20th century and PV in early 21st century bring something new. Pharmacovigilance brings:

• Patient should be included into the risk management
• Team work in PV is important and ISoP seems to be a good base
• Social media can be use for PV purposes
• Different tools for risk management
• Pharmacological knowledge is an important part of PV and we need to learn

how to use it

• Invite PRAC members and don´t let them fly out without discussion
• Medication adherence management is a challenge in risk management
• Medication errors are important part of risk
• We have to educate teachers and health care workers about recent PV and

its role in patient safety

Cubism vs. Pharmacovigilance

ISoP in figures

Delegates registered

384

Countries represented

60

Total room nights in the Clarion hotel

378

Posters

179

Invited lectures

31

Oral presentations

29

Delegates overview

Country # Delegates

Czech Republic 59 France 36 United Kingdom 31 USA 25 Germany 18 Sweden 12 Italy 11 Netherlands 11 Switzerland 11 Argentina 9 Portugal 9 South Korea 8 Mexico 8 Belgium 7 Slovak Republic 7 Canada 6 Ghana 6 India 6 Turkey 6 Brazil 5 Morocco 5

0 ¡ 10 ¡ 20 ¡ 30 ¡ 40 ¡ 50 ¡ 60 ¡ 70 ¡

Delegates per country

§ Gunilla Sjölin-Forsberg (Sweden) § Emily Banks (Australia) § Veronique Kugener (USA) § Yola Moride (Canada) § Rachida Soulaymani (Morocco) § Souad Skalli (Morocco) § Marco Tuccori (Italy) § Everardo Vazquez (Mexico) § Ian C.K. Wong (China - Hong Kong)

Scientific Committee

§ Medical part § Jan Petráček MD, Radek Běla MD, Assoc. Prof. Martin Votava MD § Pharmaceutical part § Mgr Tatiana Belkina, Mgr. Veronika Deščíková, PharmDr. Petra Matoulková, PhD § PharmDr. Kristýna Schneiderová, Mgr. Irena Storová,

• PharmDr. Lucie Šedová

Local Organising Committee

§ PharmDr. Jan Kostřiba, PhD § PharmDr. Eva Zimčíková, PhD § PharmDr. Jitka Pokladníková, PhD § Mgr. Karel Hloch § Mgr. Jan Vosátka § Mgr. Julie Strážnická § Mgr. Ricarda Meincke

My students and colleagues – volunteers (blue T-shirt group)

¡ § Karel Ježek § Andrea Marešová and their team

C- IN - Professional Congress Organiser

• Chairmen of all sessions
• ISoP Executive Committee
• All participants creating the scientific community

Our gratitude goes to…

Thank you for your contribution and have a safe trip back home!